CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,633,583
-30.1%
176,1310.0%0.00%
-25.0%
Q2 2023$5,197,626
+28.1%
176,1310.0%0.00%0.0%
Q1 2023$4,058,058
-24.6%
176,131
-9.0%
0.00%
-20.0%
Q4 2022$5,382,931
-12.2%
193,561
-3.1%
0.01%
-16.7%
Q3 2022$6,134,000
+3.1%
199,855
-1.1%
0.01%0.0%
Q2 2022$5,950,000
-8.5%
202,1770.0%0.01%
+20.0%
Q1 2022$6,504,000
-27.9%
202,1770.0%0.01%
-16.7%
Q4 2021$9,017,000
-11.2%
202,177
+0.4%
0.01%
-25.0%
Q3 2021$10,159,000
-34.8%
201,374
+1.4%
0.01%
-33.3%
Q2 2021$15,583,000
+67.1%
198,661
+21.6%
0.01%
+71.4%
Q1 2021$9,326,000
-27.6%
163,332
+6.1%
0.01%
-30.0%
Q4 2020$12,890,000
+152.0%
153,898
+7.8%
0.01%
+100.0%
Q3 2020$5,116,000
+52.0%
142,772
+2.6%
0.01%
+66.7%
Q2 2020$3,365,000
+76.8%
139,172
+28.1%
0.00%
+50.0%
Q1 2020$1,903,000
+0.6%
108,673
+0.1%
0.00%0.0%
Q4 2019$1,891,000
+39.2%
108,573
+22.4%
0.00%
+100.0%
Q3 2019$1,358,000
+325.7%
88,673
+476.5%
0.00%
Q2 2019$319,000
+43.7%
15,382
+60.5%
0.00%
Q1 2019$222,0009,5820.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders